Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00262-011-1172-6.

Title:
An immune-active tumor microenvironment favors clinical response to ipilimumab | Cancer Immunology, Immunotherapy
Description:
Purpose Ipilimumab, a fully human monoclonal antibody specific to CTLA-4, has been shown to improve overall survival in metastatic melanoma patients. As a consequence of CTLA-4 blockade, ipilimumab treatment is associated with proliferation and activation of peripheral T cells. To better understand various tumor-associated components that may influence the clinical outcome of ipilimumab treatment, gene expression profiles of tumors from patients treated with ipilimumab were characterized. Experimental design Gene expression profiling was performed on tumor biopsies collected from 45 melanoma patients before and 3 weeks after the start of treatment in a phase II clinical trial. Results Analysis of pre-treatment tumors indicated that patients with high baseline expression levels of immune-related genes were more likely to respond favorably to ipilimumab. Furthermore, ipilimumab appeared to induce two major changes in tumors from patients who exhibited clinical activity: genes involved in immune response showed increased expression, whereas expression of genes for melanoma-specific antigens and genes involved in cell proliferation decreased. These changes were associated with the total lymphocyte infiltrate in tumors, and there was a suggestion of association with prolonged overall survival in these patients. Many IFN-γ-inducible genes and Th1-associated markers showed increased expression after ipilimumab treatment, suggesting an accumulation of this particular type of T cell at the tumor sites, which might play an important role in mediating the antitumor activity of ipilimumab. Conclusions These results support the proposed mechanism of action of ipilimumab, suggesting that cell-mediated immune responses play an important role in the antitumor activity of ipilimumab.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Science
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,626,432 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't figure out the monetization strategy.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.

Keywords {🔍}

google, scholar, pubmed, article, cas, cancer, melanoma, ipilimumab, patients, expression, cell, clinical, cells, gene, human, med, tumor, metastatic, immune, immunotherapy, survival, genes, national, immunol, wang, ctla, responses, proceedings, academy, sciences, united, states, america, privacy, cookies, content, data, chasalow, berman, tumors, profiling, activity, chen, robert, res, analysis, publish, research, search, microenvironment,

Topics {✒️}

month download article/chapter interferon-gamma-induced gene expression article cancer immunology gene expression profiling multiple cancer/testis antigens immune-mediated tumor destruction anti-ctla-4 therapy results tumor microenvironment biomarkers cd8+ t-cell recruitment gene expression profiles ifn-γ-inducible genes therapeutic antitumor efficacy cell line-tropic hiv-1 immunotherapy article bristol-myers squibb cancer immunotherapy human tyrosinase gene full article pdf privacy choices/manage cookies ceacam1 enhances invasion jackson & vafa shahabi breast cancer patients melanocyte-specific transcription ctla-4-mediated inhibition tumor immunotherapy immune-related genes ifn-gamma levels melanoma-specific antigens human cancer cells t-cell responses adaptive immune responses therapeutic potential allogeneic antibody screening total lymphocyte infiltrate national cancer institute trail-induced apoptosis tumor biopsies collected article ji immune response sox10 transcription factors cell alpha chemoattractant european economic area immunotherapy aims maria jure-kunkel gov/csr/1975_2008/ braf v600e mutation higher cd4+ icoshi lymphoattractant c-x e89–e94 yasumoto ortiz romero pl

Schema {🗺️}

WebPage:
      mainEntity:
         headline:An immune-active tumor microenvironment favors clinical response to ipilimumab
         description:Ipilimumab, a fully human monoclonal antibody specific to CTLA-4, has been shown to improve overall survival in metastatic melanoma patients. As a consequence of CTLA-4 blockade, ipilimumab treatment is associated with proliferation and activation of peripheral T cells. To better understand various tumor-associated components that may influence the clinical outcome of ipilimumab treatment, gene expression profiles of tumors from patients treated with ipilimumab were characterized. Gene expression profiling was performed on tumor biopsies collected from 45 melanoma patients before and 3 weeks after the start of treatment in a phase II clinical trial. Analysis of pre-treatment tumors indicated that patients with high baseline expression levels of immune-related genes were more likely to respond favorably to ipilimumab. Furthermore, ipilimumab appeared to induce two major changes in tumors from patients who exhibited clinical activity: genes involved in immune response showed increased expression, whereas expression of genes for melanoma-specific antigens and genes involved in cell proliferation decreased. These changes were associated with the total lymphocyte infiltrate in tumors, and there was a suggestion of association with prolonged overall survival in these patients. Many IFN-γ-inducible genes and Th1-associated markers showed increased expression after ipilimumab treatment, suggesting an accumulation of this particular type of T cell at the tumor sites, which might play an important role in mediating the antitumor activity of ipilimumab. These results support the proposed mechanism of action of ipilimumab, suggesting that cell-mediated immune responses play an important role in the antitumor activity of ipilimumab.
         datePublished:2011-12-07T00:00:00Z
         dateModified:2011-12-07T00:00:00Z
         pageStart:1019
         pageEnd:1031
         sameAs:https://doi.org/10.1007/s00262-011-1172-6
         keywords:
            Ipilimumab
            Metastatic melanoma
            Cytotoxic T lymphocyte antigen-4
            Gene expression profiling
            Immunotherapy
            Oncology
            Immunology
            Cancer Research
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1172-6/MediaObjects/262_2011_1172_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1172-6/MediaObjects/262_2011_1172_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1172-6/MediaObjects/262_2011_1172_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1172-6/MediaObjects/262_2011_1172_Fig4_HTML.gif
         isPartOf:
            name:Cancer Immunology, Immunotherapy
            issn:
               1432-0851
               0340-7004
            volumeNumber:61
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Rui-Ru Ji
               affiliation:
                     name:Bristol-Myers Squibb Company
                     address:
                        name:Bristol-Myers Squibb Company, Princeton, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Scott D. Chasalow
               affiliation:
                     name:Bristol-Myers Squibb Company
                     address:
                        name:Bristol-Myers Squibb Company, Princeton, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lisu Wang
               affiliation:
                     name:Bristol-Myers Squibb Company
                     address:
                        name:Bristol-Myers Squibb Company, Princeton, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Omid Hamid
               affiliation:
                     name:The Angeles Clinic and Research Institute
                     address:
                        name:The Angeles Clinic and Research Institute, Santa Monica, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Henrik Schmidt
               affiliation:
                     name:Aarhus University Hospital
                     address:
                        name:Aarhus University Hospital, Aarhus, Denmark
                        type:PostalAddress
                     type:Organization
               type:Person
               name:John Cogswell
               affiliation:
                     name:Bristol-Myers Squibb Company
                     address:
                        name:Bristol-Myers Squibb Company, Princeton, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Suresh Alaparthy
               affiliation:
                     name:Bristol-Myers Squibb Company
                     address:
                        name:Bristol-Myers Squibb Company, Princeton, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:David Berman
               affiliation:
                     name:Bristol-Myers Squibb Company
                     address:
                        name:Bristol-Myers Squibb Company, Princeton, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Maria Jure-Kunkel
               affiliation:
                     name:Bristol-Myers Squibb Company
                     address:
                        name:Bristol-Myers Squibb Company, Princeton, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Nathan O. Siemers
               affiliation:
                     name:Bristol-Myers Squibb Company
                     address:
                        name:Bristol-Myers Squibb Company, Princeton, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jeffrey R. Jackson
               affiliation:
                     name:Bristol-Myers Squibb Company
                     address:
                        name:Bristol-Myers Squibb Company, Princeton, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Vafa Shahabi
               affiliation:
                     name:Bristol-Myers Squibb Company
                     address:
                        name:Bristol-Myers Squibb Company, Princeton, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:An immune-active tumor microenvironment favors clinical response to ipilimumab
      description:Ipilimumab, a fully human monoclonal antibody specific to CTLA-4, has been shown to improve overall survival in metastatic melanoma patients. As a consequence of CTLA-4 blockade, ipilimumab treatment is associated with proliferation and activation of peripheral T cells. To better understand various tumor-associated components that may influence the clinical outcome of ipilimumab treatment, gene expression profiles of tumors from patients treated with ipilimumab were characterized. Gene expression profiling was performed on tumor biopsies collected from 45 melanoma patients before and 3 weeks after the start of treatment in a phase II clinical trial. Analysis of pre-treatment tumors indicated that patients with high baseline expression levels of immune-related genes were more likely to respond favorably to ipilimumab. Furthermore, ipilimumab appeared to induce two major changes in tumors from patients who exhibited clinical activity: genes involved in immune response showed increased expression, whereas expression of genes for melanoma-specific antigens and genes involved in cell proliferation decreased. These changes were associated with the total lymphocyte infiltrate in tumors, and there was a suggestion of association with prolonged overall survival in these patients. Many IFN-γ-inducible genes and Th1-associated markers showed increased expression after ipilimumab treatment, suggesting an accumulation of this particular type of T cell at the tumor sites, which might play an important role in mediating the antitumor activity of ipilimumab. These results support the proposed mechanism of action of ipilimumab, suggesting that cell-mediated immune responses play an important role in the antitumor activity of ipilimumab.
      datePublished:2011-12-07T00:00:00Z
      dateModified:2011-12-07T00:00:00Z
      pageStart:1019
      pageEnd:1031
      sameAs:https://doi.org/10.1007/s00262-011-1172-6
      keywords:
         Ipilimumab
         Metastatic melanoma
         Cytotoxic T lymphocyte antigen-4
         Gene expression profiling
         Immunotherapy
         Oncology
         Immunology
         Cancer Research
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1172-6/MediaObjects/262_2011_1172_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1172-6/MediaObjects/262_2011_1172_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1172-6/MediaObjects/262_2011_1172_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1172-6/MediaObjects/262_2011_1172_Fig4_HTML.gif
      isPartOf:
         name:Cancer Immunology, Immunotherapy
         issn:
            1432-0851
            0340-7004
         volumeNumber:61
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Rui-Ru Ji
            affiliation:
                  name:Bristol-Myers Squibb Company
                  address:
                     name:Bristol-Myers Squibb Company, Princeton, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Scott D. Chasalow
            affiliation:
                  name:Bristol-Myers Squibb Company
                  address:
                     name:Bristol-Myers Squibb Company, Princeton, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lisu Wang
            affiliation:
                  name:Bristol-Myers Squibb Company
                  address:
                     name:Bristol-Myers Squibb Company, Princeton, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Omid Hamid
            affiliation:
                  name:The Angeles Clinic and Research Institute
                  address:
                     name:The Angeles Clinic and Research Institute, Santa Monica, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Henrik Schmidt
            affiliation:
                  name:Aarhus University Hospital
                  address:
                     name:Aarhus University Hospital, Aarhus, Denmark
                     type:PostalAddress
                  type:Organization
            type:Person
            name:John Cogswell
            affiliation:
                  name:Bristol-Myers Squibb Company
                  address:
                     name:Bristol-Myers Squibb Company, Princeton, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Suresh Alaparthy
            affiliation:
                  name:Bristol-Myers Squibb Company
                  address:
                     name:Bristol-Myers Squibb Company, Princeton, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:David Berman
            affiliation:
                  name:Bristol-Myers Squibb Company
                  address:
                     name:Bristol-Myers Squibb Company, Princeton, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Maria Jure-Kunkel
            affiliation:
                  name:Bristol-Myers Squibb Company
                  address:
                     name:Bristol-Myers Squibb Company, Princeton, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Nathan O. Siemers
            affiliation:
                  name:Bristol-Myers Squibb Company
                  address:
                     name:Bristol-Myers Squibb Company, Princeton, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jeffrey R. Jackson
            affiliation:
                  name:Bristol-Myers Squibb Company
                  address:
                     name:Bristol-Myers Squibb Company, Princeton, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Vafa Shahabi
            affiliation:
                  name:Bristol-Myers Squibb Company
                  address:
                     name:Bristol-Myers Squibb Company, Princeton, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cancer Immunology, Immunotherapy
      issn:
         1432-0851
         0340-7004
      volumeNumber:61
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Bristol-Myers Squibb Company
      address:
         name:Bristol-Myers Squibb Company, Princeton, USA
         type:PostalAddress
      name:Bristol-Myers Squibb Company
      address:
         name:Bristol-Myers Squibb Company, Princeton, USA
         type:PostalAddress
      name:Bristol-Myers Squibb Company
      address:
         name:Bristol-Myers Squibb Company, Princeton, USA
         type:PostalAddress
      name:The Angeles Clinic and Research Institute
      address:
         name:The Angeles Clinic and Research Institute, Santa Monica, USA
         type:PostalAddress
      name:Aarhus University Hospital
      address:
         name:Aarhus University Hospital, Aarhus, Denmark
         type:PostalAddress
      name:Bristol-Myers Squibb Company
      address:
         name:Bristol-Myers Squibb Company, Princeton, USA
         type:PostalAddress
      name:Bristol-Myers Squibb Company
      address:
         name:Bristol-Myers Squibb Company, Princeton, USA
         type:PostalAddress
      name:Bristol-Myers Squibb Company
      address:
         name:Bristol-Myers Squibb Company, Princeton, USA
         type:PostalAddress
      name:Bristol-Myers Squibb Company
      address:
         name:Bristol-Myers Squibb Company, Princeton, USA
         type:PostalAddress
      name:Bristol-Myers Squibb Company
      address:
         name:Bristol-Myers Squibb Company, Princeton, USA
         type:PostalAddress
      name:Bristol-Myers Squibb Company
      address:
         name:Bristol-Myers Squibb Company, Princeton, USA
         type:PostalAddress
      name:Bristol-Myers Squibb Company
      address:
         name:Bristol-Myers Squibb Company, Princeton, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Rui-Ru Ji
      affiliation:
            name:Bristol-Myers Squibb Company
            address:
               name:Bristol-Myers Squibb Company, Princeton, USA
               type:PostalAddress
            type:Organization
      name:Scott D. Chasalow
      affiliation:
            name:Bristol-Myers Squibb Company
            address:
               name:Bristol-Myers Squibb Company, Princeton, USA
               type:PostalAddress
            type:Organization
      name:Lisu Wang
      affiliation:
            name:Bristol-Myers Squibb Company
            address:
               name:Bristol-Myers Squibb Company, Princeton, USA
               type:PostalAddress
            type:Organization
      name:Omid Hamid
      affiliation:
            name:The Angeles Clinic and Research Institute
            address:
               name:The Angeles Clinic and Research Institute, Santa Monica, USA
               type:PostalAddress
            type:Organization
      name:Henrik Schmidt
      affiliation:
            name:Aarhus University Hospital
            address:
               name:Aarhus University Hospital, Aarhus, Denmark
               type:PostalAddress
            type:Organization
      name:John Cogswell
      affiliation:
            name:Bristol-Myers Squibb Company
            address:
               name:Bristol-Myers Squibb Company, Princeton, USA
               type:PostalAddress
            type:Organization
      name:Suresh Alaparthy
      affiliation:
            name:Bristol-Myers Squibb Company
            address:
               name:Bristol-Myers Squibb Company, Princeton, USA
               type:PostalAddress
            type:Organization
      name:David Berman
      affiliation:
            name:Bristol-Myers Squibb Company
            address:
               name:Bristol-Myers Squibb Company, Princeton, USA
               type:PostalAddress
            type:Organization
      name:Maria Jure-Kunkel
      affiliation:
            name:Bristol-Myers Squibb Company
            address:
               name:Bristol-Myers Squibb Company, Princeton, USA
               type:PostalAddress
            type:Organization
      name:Nathan O. Siemers
      affiliation:
            name:Bristol-Myers Squibb Company
            address:
               name:Bristol-Myers Squibb Company, Princeton, USA
               type:PostalAddress
            type:Organization
      name:Jeffrey R. Jackson
      affiliation:
            name:Bristol-Myers Squibb Company
            address:
               name:Bristol-Myers Squibb Company, Princeton, USA
               type:PostalAddress
            type:Organization
      name:Vafa Shahabi
      affiliation:
            name:Bristol-Myers Squibb Company
            address:
               name:Bristol-Myers Squibb Company, Princeton, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Bristol-Myers Squibb Company, Princeton, USA
      name:Bristol-Myers Squibb Company, Princeton, USA
      name:Bristol-Myers Squibb Company, Princeton, USA
      name:The Angeles Clinic and Research Institute, Santa Monica, USA
      name:Aarhus University Hospital, Aarhus, Denmark
      name:Bristol-Myers Squibb Company, Princeton, USA
      name:Bristol-Myers Squibb Company, Princeton, USA
      name:Bristol-Myers Squibb Company, Princeton, USA
      name:Bristol-Myers Squibb Company, Princeton, USA
      name:Bristol-Myers Squibb Company, Princeton, USA
      name:Bristol-Myers Squibb Company, Princeton, USA
      name:Bristol-Myers Squibb Company, Princeton, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(160)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.12s.